CAS: 15442-64-5; Zinc(Ii) 3,3'-(3,8,13,17-Tetramethyl-7,12-Divinylporphyrin-2,18-Diyl)Dipropionate

该化合物是当锌离子与环氧四丙烯酸九这一环状四丙烯结合时形成的一种铬化化合物,其特点是亮红色,这是Porphyrin环系内电子转换的结果.该化合物在各种生物过程中起着重要作用,特别是在甲型新陈代谢方面,它可以作为缺铁和铅接触的生物标志.锌丙烯烃在有机溶剂和显露的荧光特性中是可溶的,因而在各种分析应用中有用.其稳定性受pH和其他金属离子的影响,这些离子可能影响到其形成和功能.在临床环境中,血液中锌丙烯酸浓度的升高可能表明,乳腺合成受损,通常与贫血或铅中毒等条件有关.

结构式图片

上下游产品

CAS号553-12-8 原卟啉

合成工艺路线路线简述

    专利信息


    专利号:US-8889378-B2
    优先权日:2006-08-01
    标题 :Cytochrome C synthesis inhibitors
    发明人:KRANZ ROBERT
    权利人:KRANZ ROBERT; UNIV ST LOUIS
    摘要:The invention provides methods for identifying a compound that inhibits cytochrome c synthesis. This invention further provides a method for the high throughput screening of compounds that inhibit cytochrome c synthesis.

    专利号:US-2008312325-A1
    优先权日:1989-07-28
    标题 :Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
    发明人:KENNEDY JAMES C; POTTIER ROY H; REID ROBERT L; SAC-MORALES ARNOLD; TOMALTY LEWIS L
    权利人:UNIV KINGSTON
    摘要:Methods of detecting and treating rapidly growing exogenous cells, such as Protista , or parasites, that preferentially accumulate a photoactivatable porphyrin in which 5-aminolevulinic acid or precursor thereof is administered to the patient, or contacted to the exogenous cells, in an amount sufficient to induce synthesis fluorescence and/or photosensitizing concentrations of a protoporphyrin IX in the exogenous cells, followed by exposure of the exogenous cells to light of photoactivating wavelengths.

    专利号:US-5955490-A
    优先权日:1989-07-28
    标题 :Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
    发明人:KENNEDY JAMES C; POTTIER ROY H; REID ROBERT L; SAC-MORALES ARNOLD; TOMALTY LEWIS L
    权利人:UNIV KINGSTON
    摘要:Methods of detecting and treating rapidly growing exogenous cells, such as Protista, or parasites, that preferentially accumulate a photoactivatable porphyrin in which 5-aminolevulinic acid or precursor thereof is administered to the patient, or contacted to the exogenous cells, in an amount sufficient to induce synthesis fluorescence and/or photosensitizing concentrations of a protoporphyrin IX in the exogenous cells, followed by exposure of the exogenous cells to light of photoactivating wavelengths.

    专利号:US-6710066-B2
    优先权日:1989-07-28
    标 题 :Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
    发明人:KENNEDY JAMES C; POTTIER ROY H
    权利人:UNIV KINGSTON
    摘要:Methods of detecting and treating rapidly growing exogenous cells, such as Protista, or parasites, that preferentially accumulate a photoactivatable porphyrin in which 5-aminolevulinic acid or precursor thereof is administered to the patient, or contacted to the exogenous cells, in an amount sufficient to induce synthesis fluorescence and/or photosensitizing concentrations of a protoporphyrin IX in the exogenous cells, followed by exposure of the exogenous cells to light of photoactivating wavelengths.

    专利号:US-8748172-B2
    优先权日:2006-04-27
    标 题 :Cell modeling of heme deficiency using ferrochelatase mutations
    发明人:FERREIRA GLORIA C; SHI ZHEN
    权利人:FERREIRA GLORIA C; SHI ZHEN; UNIV SOUTH FLORIDA
    摘要:Provided herein, is a means for development of ferrochelatase variants with improved tolerance towards N-methyl protoporphyrin. Also disclosed are cell assay systems utilizing the variants, as the variants would confer resistance to N-methyl protoporphyrin inhibition and thereby keep heme synthesis uninterrupted. The variants contain loop mutations that affect the NMPP-ferrochelatase interaction, and different degrees of NMPP tolerance are obtained with the introduction of loop mutations in wild-type ferrochelatase. Also disclosed is kinetic mechanism of inhibition of ferrochelatase by NMPP, using the disclosed variants whose mutations in the “porphyrin-interacting loopâ€? motif weakened the potency of NMPP as an inhibitor.

    专利号:CN-109641914-A
    优先权日:2016-06-29
    标 题:Design and synthesis of porphyrin materials for high-efficiency organic photovoltaics

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Peng J, He J, Hu X, Xia Y. GPR30 alleviated subarachnoid hemorrhage-induced blood-brain barrier dysfunction by activating the PI3K/Akt and Nrf2/HO-1 pathways. Am J Physiol Cell Physiol. 2024 Jul 1;327(1):C65-C73. doi: 10.1152/ajpcell.00035.2024. Epub 2024 May 20.
    352:124130. doi: 10.1016/j.envpol.2024.124130. Epub 2024 May 8. 181(16):2886-2904. doi: 10.1111/bph.16356. Epub 2024 Apr 28.
    12:e17219. doi: 10.7717/peerj.17219.

    合成参考文献


    参考文献:10.1074/jbc.m113.545111
    摘要:Matta-Camacho E, Banerjee S, Hughes TS, Solt LA, Wang Y, Burris TP, Kojetin DJ. Structure of REV-ERBβ Ligand-binding Domain Bound to a Porphyrin Antagonist. Journal of Biological Chemistry. 2014 Jul;289(29):20054–66. doi: 10.1074/jbc.m113.545111.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知